Abstract: A repellent composition for repelling mice, rats, and other chewing and gnawing animals which deters nesting and habitation in agricultural seeds and agricultural products stored in bulk and in separate containers made from paper, burlap, cotton, plastic, wood and steel. The repellent composition is between 1 to 10% concentration of the natural concentration of commercial clove oil extract and commercially produced mustard. The composition can be sprayed and sprinkled on the ground, on the storage bags and containers, and it maintains effectiveness over an extended period of time.

Abstract: Provided is a nutraceutical composition including a glucosamine based component. The composition is effective to improve fertility in mammals, including humans and stallions. A method for improving fertility in a mammal using glucosamine based nutraceutical composition is also provided.

Abstract: Nutraceutical compositions derived from the fruit of the Garcinia mangostana L. or mangosteen plant are provided. The nutraceutical mangosteen compositions employ novel combinations of mangosteen fruit pulp and pericarp, and can be additionally complemented by selected juice concentrates to yield a composition for improving general health and wellness in humans.

Abstract: The present invention provides a pharmaceutical that includes, in combination, a resinate and an aversive agent. The resinate includes an ion exchange resin and an drug. The drug is a controlled substance. In variants of the invention, both the aversive agent and the controlled substance are loaded onto the ion exchange resin; the aversive agent is loaded onto the ion exchange resin, and the controlled substance is not loaded onto the ion exchange resin; the controlled substance is loaded onto the ion exchange resin, and the aversive agent is not loaded onto the ion exchange resin; or, the controlled substance is loaded onto a first ion exchange resin, and the aversive agent is loaded onto an ion exchange resin different from the first ion exchange resin.

Abstract: The present invention relates to methods of preventing or inhibiting the growth of Helicobacter through the use of a composition that comprises a glucosinolate, an isothiocyanate or a derivative or metabolite thereof. The present invention also relates to methods of preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer in subjects at risk for, or in need of treatment thereof.

Abstract: The present invention relates to a diet composition comprising raw foods comprising the lyophilized powders of grains, vegetables and seaweeds; dietary fibers; and functional herbal extracts, etc. The composition according to the present invention is effective in reduction of weight and body fat and body shape management as well as abundant in nutrition ingredients. And also the composition has an excellent effect on decreasing cholesterol and neutral fat amounts in blood. Therefore, the composition according to the invention can be usefully employed as a food capable of preventing or improving obesity while assisting in ingesting nutriments, which are apt to be lacking in modern people, without omission.

Abstract: The present invention relates to an antibacterial composition, comprising as an active ingredient saponificated vegetable oil, preferably soybean oil, or one or more components thereof; and at least one carrier. Also a ready-to-use composition comprising a with water diluted composition and a process for the production of an above composition is disclosed. Use of a saponificated vegetable oil, preferably soybean oil, or one or more components thereof is disclosed. Additionally the present invention relates to a method for controlling bacteria on pests comprising the application of an anti-bacterially effective amount of an above composition onto said pests.

Abstract: The present invention provides a composition for enhancing growth factor production, comprising a plant-derived enhancer for growth factor production; a therapeutic agent or prophylactic agent for a disease requiring enhancement of growth factor production and a food, beverage or feed for enhancing growth factor production, each comprising the above composition. In addition, the present invention relates to a functional food, beverage or feed excellent in health enhancement.

Abstract: A method of extracting non-polar isothiocyanates from a plant includes providing fresh or dehydrated plant material that contains at least one glucosinolate that will form a corresponding non-polar isothiocyanate, and endogenous myrosinase enzyme. Water is added to the plant material and milled, and oil is added thereafter to the water and plant mixture. This mixture is then homogenized after which the oil phase is separated from water phase and solids, such that the non-polar isothiocyanate(s) partition into the oil phase. A stable composition made according to the method includes at least one non-polar isothiocyanate and a vegetable oil. A dietary supplement may be formulated from the stable composition.

Abstract: The invention provides a novel biopesticide comprised of Whole Ground Oriental Mustard for controlling soil born pathogens such as fungi and damaging nematodes. The present invention can replace many synthetically produced pesticides such as organophosphates and methyl bromide, which are damaging to the environment and to human health.

Abstract: A nutritional supplement for providing, and for promoting the health of salivary glands and/or supporting normal or healthy swallowing includes ingredients obtainable from turmeric, ginger, and horseradish. The nutritional supplement may also be used to treat symptoms such as symptoms of a common cold, sore throat, congestion, mucositis, laryngitis, mucous membrane inflammation and sialorrhea, as well as inflammation and viral infectin, or to inhibit or exterminate a virus. This nutritional supplement can be orally administered a person. The nutritional supplement may further include optional ingredients such as ingredients obtainable from slippery elm bark powder and green tea, as well as other optional ingredients. This nutritional supplement may further include a pharmaceutically acceptable carrier for oral administration.

Abstract: Suspensions, emulsions or dispersions of therapeutically active agents which are water insoluble or water intolerant such as nutritional supplements, herbal products, drugs, bacteria, yeast, vitamins and minerals are prepared as suspensions in edible vegetable oils such as orange, lemon, soybean, cotton seed, peanut, canola corn oil, sunflower, safflower, palm kernel, palm and coconut. The active therapeutic agent may be in crystalline or amorphous form, it may be a liquid as for example an oil such as vitamin B or beta carotene, or a preparation of a comminuted plant structure such as flower, parts, leaf; stern, root or tree bark, or an extract of a dried plant structure or a freeze dried preparation of a vital bacteria or yeast. The suspension is formed by active mixing of the active agent and oil.

Abstract: A process for producing 2-furfurylthiol (“FFT”) in Brassica seed includes heating Brassica seed under a temperature and for a time sufficient to produce an elevated amount of FFT in the Brassica seed. The heated seed may be extracted and/or otherwise treated, and may be used to provide a flavorant or odorant to consumables such as foods.

Abstract: A food, medicine and cosmetic containing at least one member selected from the group consisting of broccoli, cauliflower, kale, shepherd's purse, suzushiro (Arabis flagellosa Miq.), hatazao (Arabis glabra), tagarashi (Cardamine flexuosa), woad, oobatanetsukebana (Cardamine scutata), yamagarashi (Barbarea vulgaris R. Br. var. stricta Regel), watercress, takana (Brassica juncea Czern. et Coss. var. integrifolia Sinsk.), karashina (Brassica juncea Czern. et Coss.), Japanese horseradish, yuriwasabi (Wasabia tenuis), hinona (Brassica campestris var. akana), sugukina (Brassica campestris var. neosuguki), turnip, rape, cabbage, spinach, komatsuna (Brassica rapa L.), celery, parsley, lettuce, apple, Chinese cabbage, brussels sprouts, Japanese radish and Japanese radish leaves; and a method for preventing or treating a disease, comprising ingestion or administration of an effective amount of these vegetables and fruit.

Abstract: The present invention relates to an insecticidal composition isolated from plants, and more particularly, to insecticide composition comprising Paeonia suffruticosa, Cnidium officinale, Cinnamomum cassia, cinnamon (the stem bark of C. cassia), mustard (Brassica juncea) and horseradish (Cholearia aroracia). Also, the present invention provides insecticidal compounds including trans-cinnamaldehyde, cinamyl alcohol, salicylaldehyde, allyl isothiocyanate and butyl isothiocyanate.

Abstract: A method and composition for controlling fossorial rodents are disclosed. The composition is a mixture of water, a foaming agent and a respiratory irritant. The respiratory irritant is preferably finely ground white mustard seeds. The mixture is aerated through a nozzle and pumped into the rodent burrow to exterminate the resident rodent.

Abstract: Antifungal compositions having enhanced antifungal activity comprising an antifungal agent and a food additive are described. Also described are a method for inhibiting fungal growth using the compositions with enhanced activity and the use of a food additive to enhance the antifungal properties of an antifungal agent.

Abstract: The present invention relates generally to a method of improving the antioxidant status of an infant. More particularly, the present invention relates to a method of improving the antioxidant status of an infant by administering a mixture of natural tocopherols. The natural tocopherol mixture is an effective blend of &agr;- and &ggr;-tocopherol. For ease of administration and improved taste, the mixture of natural tocopherols are typically delivered in vehicle which may be in the form, for example, of a tablet, capsule, liquid, and nutritional formula. The present invention also relates to a method of improving the antioxidant status of an infant by supplementing the lactating woman wherein the supplemented breast milk is fed to the infant. Additionally, the present invention relates to a method of improving the antioxidant status of a newborn infant by supplementing the pregnant woman.

Abstract: A nutritional supplement for promoting the health of salivary glands and supporting the normal or healthy swallowing in a person includes ingredients obtainable from turmeric, ginger, and horseradish. The nutritional supplement may also be used to treat symptoms such as symptoms of a common cold, a sore throat, congestion, mucositis, laryngitis, arthritis, mucous membrane inflammation and sialorrhea is disclosed. This nutritional supplement can be orally administered a person. The nutritional supplement may further include optional ingredients such as ingredients obtainable from slippery elm bark powder and green tea, as well as other optional ingredients. This nutritional supplement may further include a pharmaceutically acceptable carrier for oral administration.

Abstract: Cosmetic and/or pharmaceutical compositions which contain: (a) a Brassicaceae extract; and (b) one or more compounds selected from the group consisting of oil components, emulsifiers, antioxidants and UV/IR protection factors are described, along with methods for preparing and using the same.

Abstract: The present invention relates in part to compositions comprising salts of an analgesic agent and an oil, and methods of using and making the same. In certain embodiments, the compositions may be used as part of a treatment regimen to alleviate pain.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A micro-encapsulated pepper-mustard composition which comprises positioning pepper and mustard mixtures within a cluster of surfactant molecules, i.e. micelles, dispersed in water. This micro-encapsulation process involves first forming the micelles in water by exceeding the given critical micelle concentration for either one, two, or three different surfactant types. The active ingredient, pepper and mustard, is then added to this mixture and subsequently emulsified into small liquid drops in order to facilitate swelling of the micelles by way of migration or diffusion of the active ingredient molecules through the water phase and into the micelles. The resulting encapsulated pepper and mustard is effectively stabilized by the surfactant molecules, and the resulting stabilized micro-encapsulated dispersion will not undergo phase separation.

Abstract: A novel composition for treating symptoms such as symptoms of a common cold, a sore throat, congestion, laryngitis, mucous membrane inflammation and sialorrhea is disclosed. The composition includes ingredients to obtainable from turmeric extract, ginger root powder, and horseradish root powder. This composition can be orally administered a patient. The composition may further include ingredients obtainable from slippery elm bark powder and green tea. This composition may further include a pharmaceutically acceptable carrier for oral administration.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an. aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A composition for a dietary supplement supplies components to increase the cellular formation of ATP, and thus provide energy for cellular activity. Active ingredients include 4-aminobenzoic acid, 4-hydroxybenzoic acid, L-cysteine, L-methionine, sodium molybdate, selenium, lithium bromide, horseradish powder, and shiitake mushroom powder. The composition of the present invention is administered in an oral dosage form to increase energy in humans.

Abstract: A process for producing an antibacterial substance which comprises disintegrating at least a part of a plant tissue and releasing the antibacterial substance therefrom; and antibacterial or bacteriostatic compositions containing the antibacterial substance thus obtained as the active ingredient. By using the above process and compositions, the proliferation of spore-forming bacteria can be efficiently inhibited.

Abstract: The use of phospholipids of animal origin, rich in unsaturated fatty acids of the n-3 series to produce a suitable dietetic and/or pharmaceutical preparation for improving or restoring good mood, fighting against depressive states, chronic fatigue syndrome and asthenia, as well as for attenuating hyperactivity syndrome which can be associated with vegetable oils rich in unsaturated fatty acids of the n-3 series and/or fish oil, and/or vitamins.

Abstract: The subject invention provides methods of inducing the loss of adipose tissue by providing a diet high in calcium. In one aspect of the invention, the calcium is provided in the form of dairy products. In yet another aspect of the invention, calcium is provided in the form of a dietary supplement, such as calcium carbonate, of vitamin supplements. Methods of suppressing [Ca2+]i levels in individuals are also provided. The subject invention also provides methods of stimulating lipolysis, inhibiting lipogenesis, and increasing the expression of white adipose tissue uncoupling protein 2 (UPC2). The subject invention also provides methods of increasing the core temperature of an individual.

Abstract: A medical composition to nutritionally support hormone balance by promoting estrogen metabolism and increasing its excretion is disclosed. Nutritional support with the medical composition results in improvement in symptoms associated with hormone imbalance. Quality-of-life data and steroid hormone markers also shows improvement over the course of administration of the medical composition.

Abstract: A sustained/prolonged release pharmaceutical dosage form is disclosed. The form comprises a hard shell capsule and a formulation comprising (a) a water insoluble medicament, (b) a high melting fatty ester, (c) a low viscosity oil, (d) a cellulosic polymer, and (e) a non-ionic surfactant.

Abstract: The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs.

Abstract: A composition includes at least one processed dehydrated brassica vegetable containing glucosinolates and endogenous myrosinase enzyme, wherein the endogenous myrosinase enzyme converts the glucosinolates into isothiocyanates when the composition is ingested. A method of making the composition is also provided.

Abstract: A mixed substance for treating hypertension, constipation, detoxification, boost immune system produced by extracting arctium lappa L., carrot, and whole radish with water one or two hours at temperature 70° C. 100° C. under agitating, separated the extracts and solid by-products, vacuum condensed the extracts, then at low temperature lyophilized condensed extracts to powder, encapsulated powder or pressed powder to tablet. Patient taking a daily dosage of this vegetable medicine have shown greatly improved healthy condition.

Abstract: Disclosed is a pharmaceutical composition comprising at least one canola extract effective in inhibiting cell proliferation in at least one form of cancer and a pharmaceutically acceptable excipient. Also disclosed are methods of use thereof.

Abstract: Disclosed is a pharmaceutical composition comprising at least one canola extract effective in reducing hyperlipidemia and a pharmaceutically acceptable excipient. Also disclosed are methods of use thereof.

Abstract: The present invention provides novel adjuvants which comprise oil bodies. The invention also provides vaccine formulations comprising oil bodies and an antigen and methods for preparing the vaccines and the use of the vaccines to elicit an immune response.

Abstract: Disclosed is a method for preparing an aqueous phytosphingosine solution containing as much as 5-10 weight % of phytosphingosine without using any solvents other than water. A high content of phytosphingosine is dissolved in water and lactic acid with the help of a willow bark extract. In addition to being clear, the aqueous phytosphingosine solution is able to recover damaged skin with activity against bacteria and inflammation. Also, when being applied for cosmetics, the aqueous phytosphingosine solution allows them to contain as much as 1-2 weight % of phytosphingosine by virtue of its high content of phytosphingosine. Further, the phytosphingosine solution is greatly improved in compatibility with cosmetic components so that it can be readily applied for aqueous cosmetics such as skin lotions, essence lotions, aqueous pack products, body essence compositions, etc., for which phytosphingosine has not yet been applied, thus far.

Abstract: A fabric protectant comprising of a carrier and a plant oil selected from the group consisting of horseradish oil, bay oil, basil oil, calamus oil, ginger oil, palmarosa oil, cinnamon oil, ylang-ylang oil, perilla oil, valerian oil, clove oil, star anise oil, milfoil oil, fennel oil, oregano oil and angelica oil, efficaciously controls fabric-related pests. In addition, a method of protecting fabric which comprises dispersing, spraying, spreading and setting an effective amount of the plant oil selected from the group given above is an excellent method to control fabric-related pests.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The invention is directed to a composition and method for correcting a dietary phytochemical deficiency, wherein the phytochemicals include sulphoraphane, naringen, hesperidin, narirutin, quercetin, &bgr;-carotene, lutein, lycopene, and isoflavones. The composition may also comprise additional vitamins and minerals.

Abstract: The present invention provides methods for obtaining phenethyl isothiocyanate (PEITC), a natural glucosinylate derivative, from plant tissue. The methods involve selection of plant tissue naturally rich in PEITC, followed by aqueous extraction under conditions that promote optimal release of PEITC from the tissue. The invention further provides plant preparations containing significant quantities of PEITC and nutraceutical formulations comprising these preparations.

Abstract: Compositions are described comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, preferably squash seeds, and, optionally, a carbohydrate source provided in an amount capable of facilitating transport of in vivo generated tryptophan across the blood brain barrier. Also described are dietary supplements, foods and beverages comprising the composition of the invention to induce sleep or provide tryptophan supplementation to individuals in need thereof.

Abstract: The present invention is directed to a natural pesticide, which comprises two oil components. The first component is selected from at least one of the volatile oils and the other component is selected from at least one of the non-volatile oils. Mixing of these two oil components greatly increases the effectiveness for use as a pesticide than if the oils were used separately.

Abstract: The purpose of the present invention is to efficiently separate and utilize the rapeseed germ. The present invention relates to a method for the production of a fraction containing a rapeseed germ as a main component, comprising crushing a rapeseed and separating said fraction. One of the specific products derived from rapeseed germ is the oil and fat prepared by extraction or expression of the rapeseed germ.